Dialysis technique modulates alpha interferon pharmacokinetics in a patient with chronic hepatitis C.

Nephrology Dialysis Transplantation

Volumn 12, Issue 12, 1997, Pages 2804-2805

  Hanrotel, C ^a   Lavaud, S ^a   Toupance, O ^a   Lebon, P ^a   Chanard, J ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; CASE REPORT; CHRONIC HEPATITIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; HEMODIALYSIS; HEPATITIS C; HUMAN; KIDNEY FAILURE; LETTER; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; UREMIA;

ADULT; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; RENAL DIALYSIS;

EID: 0030723623     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/12.12.2804b     Document Type: Letter

References (6)

1. Wills RJ. Clinical pharmacokinetics of interferons. Clin Pharmacokinet 1990; 19: 390-399
2. Grimbert P, Deray G, Lebon P et al. Pharmacokinetics of recombinant leukocyte interferon in a patient on continuous ambulatory peritoneal dialysis. Am J Nephrol 1995; 15: 175
3. Lebon P, Ponsot G, Aicardi J, Goutiere F, Arthuis M. Early intrathecal synthesis of interferon in herpes encephalitis. Biomedicine 1979; 31: 267-271
4. Hirsch MS, Tolkoff-Rubin NE, Kelly AP, Rubin RH. Pharmacokinetics of human and recombinant leukocyte inter¬feron in patients with chronic renal failure who are undergoing hemodialysis. J Infect Dis 1983; 148: 335
5. Chanard J, Lavaud S, Toupance O, Melin JP, Gillery P, Revillard JP. b2-microglobulin-associated amyloidosis in chronic haemodia-lysis patients. Lancet 1986; 1: 1212
6. Izopet J, Rostaing L, Moussion F, Alric L, Dubois M, Ton That H, Payen JL, Duffaut M, Durand D, Suc JM, Puel J. HCV RNA clearance by haemodialysis patients with or without HGV/HGBV-C infection after alpha-interferon therapy. J Infect Dis (in press)